Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells

BACKGROUND: Ovarian cancer is the leading cause of death for gynecological cancers and the 6th cause of women cancer death in developed countries. The late stage detection, the peritoneal dissemination and the acquisition of resistance against carboplatin are the main reasons to explain this poor pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Thibault, Benoît, Jean-Claude, Bertrand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405511/
https://www.ncbi.nlm.nih.gov/pubmed/28446239
http://dx.doi.org/10.1186/s13048-017-0319-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405511/
https://www.ncbi.nlm.nih.gov/pubmed/28446239
http://dx.doi.org/10.1186/s13048-017-0319-2

Ejemplares similares